000 01481 a2200433 4500
005 20250513190520.0
264 0 _c19990825
008 199908s 0 0 eng d
022 _a0262-0898
024 7 _a10.1023/a:1006665616932
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWebber, M M
245 0 0 _aModulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).
_h[electronic resource]
260 _bClinical & experimental metastasis
_cMay 1999
300 _a255-63 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aApoptosis
650 0 4 _aCarcinoma
_xmetabolism
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCell Movement
_xdrug effects
650 0 4 _aEpithelial Cells
_xmetabolism
650 0 4 _aFenretinide
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aPhenotype
650 0 4 _aProstatic Neoplasms
_xmetabolism
650 0 4 _aReceptors, Retinoic Acid
_xbiosynthesis
650 0 4 _aTumor Cells, Cultured
650 0 4 _aUp-Regulation
_xdrug effects
650 0 4 _aVimentin
_xbiosynthesis
700 1 _aBello-DeOcampo, D
700 1 _aQuader, S
700 1 _aDeocampo, N D
700 1 _aMetcalfe, W S
700 1 _aSharp, R M
773 0 _tClinical & experimental metastasis
_gvol. 17
_gno. 3
_gp. 255-63
856 4 0 _uhttps://doi.org/10.1023/a:1006665616932
_zAvailable from publisher's website
999 _c10389797
_d10389797